Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.93 Analyst target: $9.67 Upside: 401.04%
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado.
See the full interactive analysis & chart →Informational only — not investment advice.